Groundwork BioAg completes $18 million Series B round to decarbonize mainstream agriculture
Hybrid
GROUNDWORK BIOAG RAISES $18 MILLION TO ACCELERATE DECARBONIZATION OF MAINSTREAM AGRICULTURE
Expands Farmers’ Access to Mycorrhizal BioPlatform Globally
MAZOR, ISRAEL – August 18, 2022 – Groundwork BioAg, a leading producer of mycorrhizal inoculants with broad benefits for mainstream agriculture, has completed an $18 million Series B raise. The round was led by Climate Innovation Capital (ClimateIC) with participation from HSBC Asset Management (HSBC AM), BASF Venture Capital and Edaphon (a climate-focused fund), as well as individual investor John Abele, Co-Founder and former CEO of Boston Scientific. All previous investors, including MoreVC, Middleland Capital and Ibex Investors also participated in the round.
Read full article here.
Important Disclaimer
This article is for informational purposes only and represents the opinions and views of the author. It is not intended to be used as a general guide to investing or as a source of any specific investment recommendation. It is not an offer or solicitation for the purchase or sale of any financial instrument, investment product or service. Ibex Investors LLC (“Ibex”) is not responsible for investment results or actions taken based on any recommendations or viewpoints presented in this article. This article contains information and data compiled from sources the author has deemed reliable. Ibex is not responsible for errors or omissions in this information and no representation or warranty, express or implied, is made by Ibex as to its accuracy, completeness or correctness. Additionally, this article contains forward-looking statements and actual results may differ materially from those contemplated by such forward-looking statements. The author undertakes no obligation to update these statements as a result of new information or future events.